Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 01, 2024

BUY
$41.99 - $62.38 $1,091 - $1,621
26 Added 2.22%
1,198 $70,000
Q3 2023

Oct 11, 2023

BUY
$27.8 - $45.35 $4,670 - $7,618
168 Added 16.73%
1,172 $51,000
Q2 2023

Aug 03, 2023

SELL
$36.13 - $49.49 $867 - $1,187
-24 Reduced 2.33%
1,004 $36,000
Q1 2023

Apr 28, 2023

SELL
$36.54 - $54.26 $1,717 - $2,550
-47 Reduced 4.37%
1,028 $38,000
Q4 2022

Feb 01, 2023

SELL
$41.27 - $98.62 $206 - $493
-5 Reduced 0.46%
1,075 $49,000
Q2 2022

Jul 28, 2022

BUY
$39.16 - $88.71 $38,533 - $87,290
984 Added 1025.0%
1,080 $73,000
Q1 2022

Apr 21, 2022

BUY
$75.82 - $150.97 $5,762 - $11,473
76 Added 380.0%
96 $8,000
Q4 2021

Jan 31, 2022

SELL
$132.01 - $190.29 $3,432 - $4,947
-26 Reduced 56.52%
20 $3,000
Q4 2019

Jan 27, 2020

SELL
$70.76 - $128.86 $35,663 - $64,945
-504 Reduced 91.64%
46 $6,000
Q1 2019

Apr 22, 2019

BUY
$43.65 - $78.95 $24,007 - $43,422
550 New
550 $40,000

Others Institutions Holding MRTX

About Mirati Therapeutics, Inc.


  • Ticker MRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,609,800
  • Description
  • Mirati Therapeutics, Inc., a clinical-stage oncology company, develops product candidates to address the genetic and immunological promoters of cancer in the United States. The company develops MRTX849, a KRAS G12C inhibitor, which is in Phase 1/2 clinical trial for treating non-small cell lung (NSCL), colorectal, pancreatic, and other cancers; ...
More about MRTX
Track This Portfolio

Track Cwm, LLC Portfolio

Follow Cwm, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cwm, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cwm, LLC with notifications on news.